When the Medication Meant to Help Makes Things Worse

Home › Mental Health

Keith Lacy

Updated Apr 4, 2026

Share

Abilify (aripiprazole) is prescribed as an add-on treatment for depression and certain mood disorders, but a meaningful number of people report that Abilify makes social anxiety worse rather than better. This appears to happen because aripiprazole acts as a partial dopamine agonist, which can increase agitation, restlessness, and heightened emotional sensitivity in people who are already wired to process social situations intensely. If you’ve started Abilify and noticed your social discomfort climbing instead of easing, you’re experiencing something that deserves a real conversation with your prescribing doctor.

My own experience with anxiety management didn’t involve Abilify specifically, but I know what it’s like to try something that’s supposed to quiet the noise inside and find it turns the volume up instead. Running an advertising agency for two decades meant I spent a lot of time in rooms full of people, presenting to Fortune 500 clients, managing teams, fielding calls I didn’t want to take. I tried various approaches over the years to manage the social exhaustion that came with that life. Some helped. Some made things considerably worse. And the ones that made things worse were often the hardest to identify, because I kept assuming the problem was me, not the approach.

If you’re an introvert or a highly sensitive person dealing with social anxiety, the intersection of medication, personality, and mental health is genuinely complicated territory. Our Introvert Mental Health Hub covers this intersection in depth, from the roots of anxiety to the specific emotional patterns that shape how introverts and sensitive people experience mental health challenges. This article focuses specifically on what happens when Abilify and social anxiety collide in ways nobody warned you about.

What Is Abilify Actually Doing in Your Brain?

Abilify is an atypical antipsychotic, which is a category name that sounds alarming if you’ve been prescribed it for depression or anxiety. Doctors often add it to an existing antidepressant when the antidepressant alone isn’t producing enough relief. The mechanism is genuinely unusual compared to most psychiatric medications. Rather than simply blocking or flooding a particular receptor, aripiprazole acts as a partial agonist at dopamine D2 receptors, meaning it can either stimulate or dampen dopamine activity depending on the existing levels in a given brain region.

That partial agonist quality is what makes Abilify interesting to prescribers and complicated for patients. In someone with very low dopamine activity, it nudges things upward. In someone with higher dopamine tone, it can have a stabilizing or even suppressing effect. The problem is that this mechanism doesn’t operate cleanly across the whole brain. Some regions may get more dopamine stimulation while others get less, and the downstream effects on mood, motivation, and social behavior can be unpredictable.

One of the most commonly reported side effects of Abilify is akathisia, a state of inner restlessness that can feel like crawling anxiety, an inability to sit still, or a constant low-grade sense of agitation. For someone already managing clinical anxiety, akathisia can be genuinely indistinguishable from a worsening of their core symptoms. You feel more anxious, more activated, more on edge, and the natural interpretation is that your anxiety is getting worse, not that a medication side effect is mimicking anxiety’s signature.

Why Sensitive and Introverted People May Be More Vulnerable to This Effect

Not everyone who takes Abilify experiences increased social anxiety. But certain profiles seem to be more susceptible, and introverts and highly sensitive people (HSPs) appear to be among them. The reason has less to do with personality as a category and more to do with how the nervous system is calibrated in people who process information deeply and feel things intensely.

Highly sensitive people already operate with a nervous system that picks up more signal from the environment. Social situations carry more data: more emotional cues to read, more potential for misreading, more sensory input to process. That depth of processing is a genuine strength in many contexts, but it also means that any medication that increases neural activation or agitation is going to interact with an already finely tuned system. The sensory overload that HSPs experience in ordinary social settings can become significantly amplified when a medication is simultaneously raising the baseline level of internal arousal.

I’ve watched this dynamic play out in people I’ve worked with, even outside a clinical context. One of my account directors at the agency was a deeply sensitive person who processed everything at a level most of the team didn’t notice. She would pick up on client tension before anyone else in the room. She’d catch the slight hesitation in a presentation response that signaled trouble ahead. That sensitivity was extraordinary in a business context. But it also meant she was running hotter than most people, neurologically speaking. Any additional stimulation, whether it was a difficult client meeting or a medication side effect, hit her system harder than it would have hit someone less attuned.

The anxiety patterns common in HSPs are worth understanding in this context, because they shape how medication side effects get interpreted. When your baseline is already one of heightened alertness to social threat, a medication that increases agitation doesn’t feel like a side effect. It feels like confirmation of what you already feared: that social situations are dangerous, that people are judging you, that you can’t handle being around others. The medication isn’t creating those thoughts from scratch. It’s providing the physiological fuel that makes existing thought patterns feel more true.

The Akathisia Problem: When Restlessness Looks Like Social Anxiety

Akathisia deserves its own focused discussion because it’s one of the most underrecognized reasons why Abilify makes social anxiety worse for some people. The word comes from the Greek for “not sitting,” and that captures something essential about the experience. It’s not just general anxiety. It’s a specific, relentless physical and psychological restlessness that can range from mildly uncomfortable to genuinely distressing.

In social contexts, akathisia presents in ways that are almost perfectly designed to amplify social anxiety. The physical restlessness makes it hard to be still in a conversation, which triggers self-consciousness about appearing nervous. The inner agitation makes it difficult to track what someone is saying, which creates fear of being seen as disengaged or rude. The general sense of being unable to settle makes it nearly impossible to access the calm, observant state that many introverts and sensitive people rely on to feel competent in social situations.

What makes this particularly cruel is that the person experiencing it often doesn’t know what they’re feeling is a medication side effect. They attribute the restlessness to social anxiety, which reinforces their belief that they are fundamentally bad at social interaction. That belief then feeds the anxiety, which feeds the avoidance, which feeds the isolation. The medication that was supposed to help has effectively tightened the trap.

According to Harvard Health’s guidance on social anxiety disorder, recognizing the difference between medication side effects and core anxiety symptoms is a critical part of treatment, and it requires open, ongoing communication with your prescriber. Many people don’t report worsening symptoms because they assume they’re the problem, not the medication.

How Deep Emotional Processing Complicates the Picture

One of the things I’ve come to understand about my own psychology is that I don’t just experience emotions, I analyze them in real time. As an INTJ, my default mode is to observe, categorize, and search for patterns, even when the subject of observation is my own internal state. That can be useful. It can also mean that when something feels wrong, I spend considerable energy trying to understand why, which sometimes amplifies the feeling rather than resolving it.

People who engage in deep emotional processing face a specific challenge with medication-induced anxiety changes. They notice everything. They track shifts in their mood with precision. They’re aware of subtle changes in how they feel in social situations. This is not a flaw. It’s actually the kind of self-awareness that can be enormously helpful in therapy and in life. But when a medication is producing unpredictable effects, that same attentiveness can become a source of additional distress.

You notice that you feel more anxious around people than you did last week. You analyze whether something happened socially to explain it. Nothing did. You analyze whether you’re getting worse. You read about social anxiety and recognize yourself in descriptions that feel more accurate than they did before. You wonder if you’ve been underestimating how anxious you really are. What you may not consider is that a medication you started three weeks ago is producing a neurological side effect that is generating this entire spiral.

The relationship between neurological activation and social anxiety is complex, and the research in this area continues to develop. What’s clear is that medications affecting dopamine and serotonin systems can have downstream effects on social behavior and social fear that are not always predictable from the medication’s primary mechanism of action.

The Empathy Factor: Why Social Anxiety Feels Different for Sensitive People on Abilify

There’s another layer to this that doesn’t get discussed enough. Highly sensitive people and many introverts experience social situations through a strong empathic lens. They’re not just managing their own emotions in a conversation. They’re also picking up on and partially absorbing the emotional states of the people around them. That capacity is explored in depth in the context of HSP empathy as a double-edged quality, and it’s relevant here because it shapes how medication-induced anxiety gets experienced in social settings.

When Abilify increases internal agitation, it doesn’t just make you feel more anxious about yourself in social situations. It amplifies the entire social processing system. You pick up on more emotional signals from others. You feel those signals more intensely. The already-demanding task of being in a room with other people becomes more demanding still, because your system is running at a higher activation level than usual. Every perceived judgment, every moment of social ambiguity, every silence that might mean something registers with greater intensity.

I spent years in client presentations where reading the room was genuinely part of my job. I needed to track the emotional temperature of a boardroom, notice when a senior vice president was losing interest, catch the subtle signal that a creative direction wasn’t landing. That attentiveness served me well professionally. But I also know what it’s like when that same attentiveness gets hijacked by anxiety. When you’re already anxious, every social signal becomes threat data. A medication that increases anxiety doesn’t just make you feel bad. It corrupts the entire social processing system you rely on.

What Perfectionism Has to Do With Medication Response

There’s a pattern I’ve noticed in sensitive, introverted people that connects perfectionism and medication response in a way that isn’t obvious at first. Many people who struggle with social anxiety also carry strong perfectionist tendencies. They hold themselves to high standards in social performance, worry about saying the wrong thing, replay conversations after the fact, and feel acute distress when they believe they’ve made a social error. The perfectionism that HSPs often carry is deeply intertwined with their social anxiety, not a separate issue sitting alongside it.

When Abilify increases agitation or restlessness, it directly undermines the careful self-management that perfectionists use to get through social situations. The internal script that says “stay calm, think before you speak, project confidence” becomes much harder to follow when your nervous system is running hot. You make more social missteps, or you perceive that you do. Those perceived missteps feed the perfectionist self-criticism, which feeds the anxiety, which makes the next social interaction feel even more threatening.

I’ve had my own version of this. There were periods running the agency where I was managing significant stress and my anxiety was high. In those periods, my perfectionism about client interactions went into overdrive. I would over-prepare for meetings, over-analyze responses, over-rehearse presentations. The preparation was useful up to a point, but past that point it became its own source of anxiety. Any medication that raised my baseline agitation would have made that loop significantly worse, not better.

Distinguishing Between Medication Side Effects and Underlying Anxiety Worsening

One of the most practically important questions if you’re on Abilify and experiencing increased social anxiety is whether what you’re experiencing is a side effect of the medication or a genuine worsening of your underlying condition. This distinction matters because the appropriate response is very different in each case.

A few patterns tend to suggest medication side effects rather than natural anxiety progression. Timing is one of the clearest signals. If your social anxiety increased noticeably in the weeks after starting Abilify or after a dose increase, the temporal connection is significant. Anxiety that worsens for life reasons tends to track with identifiable stressors, not with prescription changes. If you can’t point to a specific social situation or life event that explains the increase, the medication deserves serious consideration as a cause.

Physical restlessness is another signal. Pure social anxiety typically produces fear and avoidance. Akathisia produces a specific quality of physical agitation, an inability to stay still, a crawling sensation, a compulsive need to move, that is different from ordinary anxiety even though it can feel similar. If your anxiety has a physical, motor quality that wasn’t there before, that’s worth describing precisely to your doctor.

The American Psychological Association’s work on shyness and social anxiety draws a useful distinction between the emotional experience of social fear and the physiological activation that accompanies it. Medications can affect these two components differently, and understanding which component is changing can help clarify whether a medication is helping or hurting.

The Rejection Sensitivity Layer

Social anxiety and rejection sensitivity are closely related but not identical. Many people with social anxiety have a particularly acute response to perceived rejection or disapproval, and that sensitivity shapes how they experience social situations at a fundamental level. Understanding how sensitive people process rejection matters here because Abilify’s effects on dopamine can directly influence rejection sensitivity.

Dopamine pathways are involved in how the brain processes social reward and social threat. When dopamine activity is altered, the calibration of what feels rewarding versus threatening in social situations can shift. For someone already prone to reading neutral social signals as potential rejection, a medication that disrupts dopamine balance can tilt that calibration further toward threat. Ordinary social ambiguity, a delayed text response, a colleague who seems distracted, a presentation that gets a lukewarm reaction, starts registering as rejection rather than noise.

I’ve been in enough high-stakes client situations to understand what it feels like when the threat-detection system is running too hot. There were pitches where I walked out genuinely uncertain whether we’d won or lost the business, and the ambiguity would sit with me for hours. That’s manageable when your baseline is calm. It’s significantly harder when your nervous system is already activated, and it’s nearly impossible when a medication is amplifying the activation further.

The neurobiological research on social anxiety points to the amygdala and prefrontal cortex as key players in how social threat is processed and regulated. Medications that affect dopamine and serotonin systems interact with these circuits in ways that can either support or undermine that regulation, depending on the individual.

What to Do If You Suspect Abilify Is Worsening Your Social Anxiety

The most important step is to tell your prescribing doctor specifically what you’re experiencing, and to do it sooner rather than later. Many people wait, assuming the side effects will pass or that they need to give the medication more time. While some side effects do resolve as the body adjusts, akathisia and anxiety-like activation from Abilify often don’t simply fade. They may require a dose adjustment, a switch to a different adjunctive medication, or discontinuation of Abilify altogether.

Be specific in how you describe what you’re experiencing. “More anxious” is less useful to a prescriber than “I feel physically restless and can’t settle in social situations, and this started about two weeks after my dose was increased.” The more precisely you can describe the timing, the quality, and the context of the change, the better positioned your doctor is to evaluate whether it’s a medication effect.

Keep a brief daily log of your anxiety level and any physical symptoms during the period you’re adjusting to or questioning a medication. This doesn’t need to be elaborate. A simple note each evening about how social situations felt that day, and whether you noticed any physical restlessness, gives your doctor something concrete to work with. It also gives you a clearer picture of patterns that might not be visible day to day.

It’s also worth understanding that introversion and social anxiety are distinct experiences that can overlap in complicated ways. Your prescriber needs to understand your baseline, including how much social interaction you naturally find draining versus anxiety-provoking, to accurately assess whether a medication is helping or hurting your specific situation.

Don’t stop Abilify abruptly without medical guidance. Discontinuation of psychiatric medications should always be done under supervision, both because stopping suddenly can cause its own symptoms and because your prescriber may want to taper you off while adjusting other parts of your treatment plan.

When the Treatment Itself Becomes the Problem

There’s something particularly disorienting about experiencing a medication side effect that mimics your core symptom. With most side effects, the signal is clear: this medication is making me nauseous, or giving me headaches, or disrupting my sleep. Those are obviously different from what you’re being treated for. But when a medication for anxiety makes you more anxious, the feedback loop becomes genuinely confusing. You can’t easily separate what’s you from what’s the medication.

I think this confusion is especially acute for introverts and sensitive people because we tend to internalize. When something feels wrong, the first place we look is inward. We ask what we’re doing wrong, what we’re thinking wrong, what we’re feeling wrong. The possibility that an external chemical is producing the feeling often comes later, if it comes at all.

The broader diagnostic framework for anxiety disorders, as outlined in the DSM-5 changes from the American Psychiatric Association, does include medication-induced anxiety as a diagnosable condition, separate from primary anxiety disorders. That distinction exists for a reason. What a medication does to your anxiety is not the same as what your anxiety is doing on its own, and treating them as the same thing leads to poor outcomes.

Effective treatment for social anxiety in introverts and sensitive people requires a prescriber who understands the specific profile they’re working with. Not all anxiety is the same. Not all patients respond to medications the same way. And a medication that helps one person manage social fear may genuinely make another person’s social world feel more threatening. That’s not a personal failing. It’s pharmacology.

If you’re working through questions about how your personality, sensitivity, and mental health intersect, the Introvert Mental Health Hub offers a fuller picture of these connections, covering everything from anxiety and sensory processing to emotional depth and the specific mental health patterns that show up in introverted and sensitive people.

About the Author

Keith Lacy is an introvert who’s learned to embrace his true self later in life. After 20 years in advertising and marketing leadership, including running agencies and managing Fortune 500 accounts, Keith now channels his experience into helping fellow introverts understand their strengths and build fulfilling careers. As an INTJ, he brings analytical depth and authentic perspective to every article, drawing from both professional expertise and personal growth.

Frequently Asked Questions

Can Abilify actually make social anxiety worse?

Yes, Abilify can worsen social anxiety in some people. The most common mechanism is akathisia, a medication side effect characterized by inner restlessness and agitation that can be difficult to distinguish from anxiety itself. Because Abilify acts on dopamine pathways that are involved in social threat processing, it can also shift how the brain interprets social situations, making ambiguous signals feel more threatening. If your social anxiety increased after starting or adjusting Abilify, this is worth discussing directly with your prescribing doctor.

What is akathisia and how does it relate to social anxiety?

Akathisia is a side effect of several psychiatric medications, including Abilify, characterized by a persistent sense of inner restlessness and an inability to stay physically still. In social contexts, this restlessness can feel nearly identical to social anxiety: physical discomfort, difficulty concentrating, a sense of agitation around other people. Many people misidentify akathisia as a worsening of their anxiety rather than a medication side effect, which leads them to believe their condition is getting worse rather than recognizing the medication as the source.

Are introverts and highly sensitive people more affected by Abilify’s side effects on anxiety?

There’s reason to believe that introverts and highly sensitive people may experience medication-induced anxiety changes more intensely, though individual responses vary considerably. HSPs and many introverts process sensory and emotional information at a deeper level and operate with a more finely calibrated nervous system. Any medication that increases neurological activation interacts with a system that is already running at a higher sensitivity level. That doesn’t mean these individuals should avoid Abilify, but it does mean their prescribers should monitor for anxiety-related side effects carefully and take reports of worsening social anxiety seriously.

How can I tell if my worsening social anxiety is from Abilify or from my underlying condition?

Timing is one of the clearest signals. If social anxiety increased noticeably in the weeks following a new prescription or dose change, the temporal connection suggests a medication effect. Physical restlessness or akathisia that wasn’t present before also points toward the medication. Anxiety that worsens from your underlying condition typically tracks with identifiable life stressors rather than prescription changes. Keeping a brief daily log of your anxiety levels and physical symptoms can help you and your doctor identify patterns and make a more informed assessment.

What should I do if I think Abilify is making my social anxiety worse?

Contact your prescribing doctor and describe specifically what you’re experiencing, including when it started, how it feels physically and emotionally, and how it’s affecting your social functioning. Be as precise as possible rather than simply saying you feel more anxious. Do not stop Abilify abruptly without medical guidance, as discontinuation should be managed carefully. Your doctor may adjust your dose, add a medication to address akathisia, or consider switching to a different adjunctive treatment. There are effective alternatives for managing depression and anxiety that may not carry the same social anxiety risks for your particular neurological profile.